Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted beta-emitting radionuclide therapies in metastatic castration-resistant prostate cancer

BACKGROUND: Prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) has demonstrated efficacy and tolerability with a dose-response effect in phase I/II trials in men with metastatic castration-resistant prostate cancer (mCRPC). The need for positive PSMA imaging prior to PSMA-...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Prostate
Hoofdauteurs: Vlachostergios, Panagiotis J., Niaz, Muhammad Junaid, Skafida, Myrto, Mosallaie, Seyed Ali, Thomas, Charlene, Christos, Paul J., Osborne, Joseph R., Molina, Ana M., Nanus, David M., Bander, Neil Harrison, Tagawa, Scott T.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2021
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904644/
https://ncbi.nlm.nih.gov/pubmed/33465252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.24104
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items